The Centre for Cellular and Molecular Platforms (C-CAMP) has announced seven awards for the inaugural edition of the C-CAMP One Health AMR Challenge, 2025, tackling Antimicrobial Resistance (AMR) across human, animal, and environmental health.
The winners for human health are: Bigtec Labs Pvt. Ltd. (A multiplexed, reverse transcription (RT)-PCR diagnostic solution that addresses antibiotic resistance in lower respiratory tract infections), Muse Diagnostics (TreBle Respire: AI-driven screening platform for early detection of respiratory infections and antimicrobial stewardship), GenePath Diagnostics (Affordable, comprehensive, modular, semi-quantitative respiratory pathogens and AMR detection panel for open PCR Platforms) and Achira Labs (Development and validation of a papid point-of-care test to distinguish bacterial from viral infections in humans: A Strategy to optimize antimicrobial stewardship.)
The winner for environment is FNDR (Depletion of antimicrobials and other active pharmaceutical ingredients (APIs) from pharmaceutical/chemical manufacturing unit effluents).
The winners for animal health are: Ultranutri (Circular solutions for shrimp health: Tackling AMR through insect-based feed) and Chimertech and Quadmastest & (Inline Quadmastest (IQ): Rapid, reagent-free early mastitis detection to prevent unwarranted antibiotic use and curb AMR in dairy health.)
“We have identified a pipeline of seven innovative solutions addressing critical gaps such as point of care tests to distinguish bacterial from viral infections in clinical care especially in respiratory tract infections (RTI), detection of specific RTI pathogens, treatment of pharmaceutical manufacturing units effluents, prevention of antibiotic use in aquaculture and dairy and so on. The first cohort holds great potential for combating AMR,” Taslimarif Saiyed, Director-CEO, C-CAMP, said.